echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > JCO: Chemotherapy combined with primary tumor removal does not improve the efficacy of patients with advanced colorectal cancer

    JCO: Chemotherapy combined with primary tumor removal does not improve the efficacy of patients with advanced colorectal cancer

    • Last Update: 2021-02-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Since PTR's follow-up chemotherapy did not show a survival benefit over chemotherapy alone, PTR should no longer be considered the standard of treatment for CRC patients with asymptomatic primary tumors and synchronous non-removable metastasis.
    treatment strategy remains controversial for patients with incurable advanced colorectal cancer (CRC).
    the study therefore assessed the benefits of increased non-invasive primary tumor excision (PTR) for standard chemotherapy for the survival of asymptomatic primary tumors and up to 3 non-removable iv-stage CRC patients with non-removable metastatic lesions.
    February 9, Journal of Clinical Oncology published an article reporting the results of this Phase III randomized control study (JCOG1007, iPACS study; UMIN identifier: UMIN000008147).
    iPACS is the first RCT to study the role of PTR in metastasis CRC cancer patients.
    between June 2012 and September 2019, the study included 165 patients selected and randomly assigned to receive chemotherapy alone (84 cases) or PTR-plus chemotherapy.
    The study looked at the advantages of PTR combined chemotherapy over chemotherapy alone in patients with asymptomatic CRC in stage IV that could not be removed and in patients with three or fewer non-removable metastatic diseases limited to liver, lung, and distant lymph node metastasis.
    120 (73%) of the 165 patients were liver metastasis, the most common non-removable metastasis.
    the distribution of two groups of non-removable metastasis diseases... MedSci Original Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Originals" are owned by Mets Medicine and are not authorized to be reproduced by any media, website or individual, and are authorized to be reproduced with the words "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.